Sun, S.; Xu, L.; Zhang, X.; Pang, L.; Long, Z.; Deng, C.; Zhu, J.; Zhou, S.; Wan, L.; Pang, B.;
et al. Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy. Cancers 2021, 13, 1639.
https://doi.org/10.3390/cancers13071639
AMA Style
Sun S, Xu L, Zhang X, Pang L, Long Z, Deng C, Zhu J, Zhou S, Wan L, Pang B,
et al. Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy. Cancers. 2021; 13(7):1639.
https://doi.org/10.3390/cancers13071639
Chicago/Turabian Style
Sun, Shangqin, Liwen Xu, Xinxin Zhang, Lin Pang, Zhilin Long, Chunyu Deng, Jiali Zhu, Shuting Zhou, Linyun Wan, Bo Pang,
and et al. 2021. "Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy" Cancers 13, no. 7: 1639.
https://doi.org/10.3390/cancers13071639
APA Style
Sun, S., Xu, L., Zhang, X., Pang, L., Long, Z., Deng, C., Zhu, J., Zhou, S., Wan, L., Pang, B., & Xiao, Y.
(2021). Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy. Cancers, 13(7), 1639.
https://doi.org/10.3390/cancers13071639